International Clinical Trial: LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07455539) titled 'LAmbre™ II Left Atrial Appendage Occluder and Occluder Delivery System for Patients With Non-Valvular Atrial Fibrillation' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Prince of Wales Hospital, Shatin, Hong Kong

Condition: Non Valvular Atrial Fibrillation

Intervention: Device: LAmbre II Left Atrial Appendage Occluder

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 1, 2026

Target Sample Size: 10

To know more, visit https://cli...